Her-2 neu negative lipid rich breast carcinoma in an immunocompromised patient
Lipid-rich breast carcinoma (LRBC) is rare cancer considered to be a variant of invasive ductal breast carcinoma. It is characterized by an aggressive behavior and poor prognosis and requires prompt recognition and close follow-up. The tumor derives its name from the intracytoplasmic neutral lipid t...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2015-12-01
|
| Series: | Human Pathology: Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2214330015201332 |
| _version_ | 1811275216895082496 |
|---|---|
| author | Deepika Sirohi, M.D. Kent Swimley Amanda L. Profit, M.D. Nicole D. Riddle, M.D. |
| author_facet | Deepika Sirohi, M.D. Kent Swimley Amanda L. Profit, M.D. Nicole D. Riddle, M.D. |
| author_sort | Deepika Sirohi, M.D. |
| collection | DOAJ |
| description | Lipid-rich breast carcinoma (LRBC) is rare cancer considered to be a variant of invasive ductal breast carcinoma. It is characterized by an aggressive behavior and poor prognosis and requires prompt recognition and close follow-up. The tumor derives its name from the intracytoplasmic neutral lipid that gives it a vacuolated appearance and is included in the current WHO classification. We report here a case of Her-2 neu negative lipid-rich carcinoma of the breast occurring in a HIV positive woman. |
| first_indexed | 2024-04-12T23:34:04Z |
| format | Article |
| id | doaj.art-a106829e8b8e41b5baad6949a7e21c38 |
| institution | Directory Open Access Journal |
| issn | 2214-3300 |
| language | English |
| last_indexed | 2024-04-12T23:34:04Z |
| publishDate | 2015-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Human Pathology: Case Reports |
| spelling | doaj.art-a106829e8b8e41b5baad6949a7e21c382022-12-22T03:12:12ZengElsevierHuman Pathology: Case Reports2214-33002015-12-01249910210.1016/j.ehpc.2015.04.002Her-2 neu negative lipid rich breast carcinoma in an immunocompromised patientDeepika Sirohi, M.D.0Kent Swimley1Amanda L. Profit, M.D.2Nicole D. Riddle, M.D.3University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USAUniversity of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USAUniversity of Texas Health Science Center at San Antonio, Dept. of Pathology, MC 7750, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USAUniversity of Texas Health Science Center at San Antonio, Dept. of Pathology, MC 7750, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USALipid-rich breast carcinoma (LRBC) is rare cancer considered to be a variant of invasive ductal breast carcinoma. It is characterized by an aggressive behavior and poor prognosis and requires prompt recognition and close follow-up. The tumor derives its name from the intracytoplasmic neutral lipid that gives it a vacuolated appearance and is included in the current WHO classification. We report here a case of Her-2 neu negative lipid-rich carcinoma of the breast occurring in a HIV positive woman.http://www.sciencedirect.com/science/article/pii/S2214330015201332Lipid-RichBreastImmunocomprised |
| spellingShingle | Deepika Sirohi, M.D. Kent Swimley Amanda L. Profit, M.D. Nicole D. Riddle, M.D. Her-2 neu negative lipid rich breast carcinoma in an immunocompromised patient Human Pathology: Case Reports Lipid-Rich Breast Immunocomprised |
| title | Her-2 neu negative lipid rich breast carcinoma in an immunocompromised patient |
| title_full | Her-2 neu negative lipid rich breast carcinoma in an immunocompromised patient |
| title_fullStr | Her-2 neu negative lipid rich breast carcinoma in an immunocompromised patient |
| title_full_unstemmed | Her-2 neu negative lipid rich breast carcinoma in an immunocompromised patient |
| title_short | Her-2 neu negative lipid rich breast carcinoma in an immunocompromised patient |
| title_sort | her 2 neu negative lipid rich breast carcinoma in an immunocompromised patient |
| topic | Lipid-Rich Breast Immunocomprised |
| url | http://www.sciencedirect.com/science/article/pii/S2214330015201332 |
| work_keys_str_mv | AT deepikasirohimd her2neunegativelipidrichbreastcarcinomainanimmunocompromisedpatient AT kentswimley her2neunegativelipidrichbreastcarcinomainanimmunocompromisedpatient AT amandalprofitmd her2neunegativelipidrichbreastcarcinomainanimmunocompromisedpatient AT nicoledriddlemd her2neunegativelipidrichbreastcarcinomainanimmunocompromisedpatient |